Sector: Pharmaceuticals & Biotechnology

Small Cap

Aptus Pharma Share Price

APPL

₹224

4.25(1.93%)

10th Jul 2026 | 2:15 PM

NSE :

Open Free Demat Account

Aptus Pharma Performance

Price Movement

N/A

₹215.50

₹224.00

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹224.00

Low₹215.50

Open at₹215.50

Prev Close₹219.75

Volumes9.60 K

Avg Price₹219.41

Lower Circuit₹215.40

Upper Circuit₹224.10

Historical Performance

3M High₹238.80

3M Low₹144.20

1 Yr High₹238.80

1 Yr Low₹32.32

3 Yr High₹238.80

3 Yr Low₹32.32

5 Yr High₹238.80

5 Yr Low₹32.32

Summary

As of 10-07-2026 22:18, Aptus Pharma Ltd. share price today is ₹0, with a change of ₹-219.75 (-100.00%) from the previous close of ₹219.75. The stock opened at ₹215.5 and traded between ₹215.5 and ₹224, with a total traded volume of 9600 shares. The company has a market capitalization of ₹376.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹238.8 and ₹32.32, respectively.

Aptus Pharma Ltd. valuation metrics include a P/E ratio of 81.6, and book value of ₹16.10. Profitability indicators show ROE of 19.78%.

Aptus Pharma Ltd. technical indicators include Day RSI at 51.85, Day MFI at 58.39, Day ADX at 37.44. Additional indicators include Commodity Channel Index (CCI) at -40.8 and Williams %R at -96.07. Momentum indicators show Day MACD at 6.7, Day MACD Signal Line at 9.5, DayATR at 4.45. Rate of Change indicators for Aptus Pharma Ltd. include ROC125 at 243.36 and ROC21 at -4.27.

Exponential moving averages include EMA5 at ₹223.9, EMA10 at ₹225.5, EMA12 at ₹225.3, EMA20 at ₹222.2, EMA26 at ₹218.6, EMA50 at ₹201.2, EMA100 at ₹167.7. Simple moving averages include SMA5 at ₹225.6, SMA10 at ₹228.4, SMA20 at ₹223.8, SMA30 at ₹219.8, SMA50 at ₹201.5, SMA100 at ₹160.9, SMA150 at ₹130.6.

Support levels for Aptus Pharma are placed at First Support ₹219.25, Second Support ₹218.75, Third Support ₹218.50. Resistance levels are seen at First Resistance ₹220.00, Second Resistance ₹220.25, Third Resistance ₹220.75. Aptus Pharma Ltd. shareholding pattern shows promoter holding at 72.89%, FII holding at 0%, DII holding at 0%, public holding at 27.11%.

Aptus Pharma Fundamentals

Market Cap

Below industry Median

376.90 Cr.

PE Ratio (TTM)

High in industry

81.60

Dividend Yield

Net Profit TTM

Net profit TTM

Net Profit Growth

Net profit TTM

PEG Ratio

ROE

56% decr over last year

19.78

Operating Revenue TTM

Operating Revenue Growth

Operating Revenue TTM

Book Value

High in industry

16.10

MFI

MFI is mid-range

58.39

RSI

RSI is mid-range

51.85

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

16.10

Aptus Pharma Financials

Data not available for chart

Indicator
No Record Found

Aptus Pharma Technicals

Aptus Pharma Ltd. EMA & SMA

₹224.00

3.75 (1.70%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹223.9

Day EMA10 ₹225.5

Day EMA12 ₹225.3

Day EMA20 ₹222.2

Day EMA26 ₹218.6

Day EMA50 ₹201.2

Day EMA100 ₹167.7

Aptus Pharma Support and Resistance

Resistance

First Resistance₹220.00

Second Resistance₹220.25

Third Resistance₹220.75

Support

First Support₹219.25

Second Support₹218.75

Third Support₹218.50

Technical Indicators

Day RSI51.85

Day MFI58.39

Day ADX37.44

Day Commodity Channel Index-40.80

William-96.07

Day MACD6.70

Day MACD Signal Line9.50

Day ATR4.45

Day ROC125243.36

Day ROC21-4.27

Aptus Pharma Shareholding Pattern

Held By	Sep 2025	Dec 2025	Mar 2026
Promoter	72.9	72.9	72.9
FII	10	0	0
DII	2.8	0	0
Public	14.3	27.1	27.1

Aptus Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	2.4 K	2.4 K	100.00%
Week	7.84 K	7.84 K	100.00%
1 Month	13.14 K	13.14 K	100.00%
6 Month	11.09 K	11.09 K	100.00%

Aptus Pharma SWOT Analysis

Strengths6

Weakness8

Opportunity0

Threats0

Annual Profit Growth higher than Sector Profit Growth

Companies with Low Debt

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Aptus Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Aptus Pharma Stock Comparison

Financials	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.
Price (₹)	₹41	₹587.60	₹183.50	₹259.30	₹35	₹5.40
% Change	0.00%	-1.43%	-0.27%	0.00%	-2.78%	-0.18%
Revenue TTM (₹ Cr)	-	-	-	-	₹1.27	₹83.60
Net Profit TTM (₹ Cr)	-	-	-	-	₹-0.25	₹-34.95
PE TTM	9.60	-	12.40	37.00	-85.20	-1.30
1 Year Return		52.07			700	441
ROCE	-	3.56	-	-	-	-5.63

Similar Stocks

AMANTA

Amanta Healthcare Ltd.

₹ 179.17

-2.00%

AHCL

Anlon Healthcare Ltd.

₹ 15.60

+0.84%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 95.00

-1.04%

APL

Asston Pharmaceuticals Ltd.

₹ 76.50

+1.32%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 535.00

-0.10%

ASTONEALAB

Astonea Labs Ltd.

₹ 282.55

+1.99%

AMWILL

Amwill Health Care Ltd.

₹ 41.00

-3.91%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 62.00

-0.26%

SHELTER

Shelter Pharma Ltd.

₹ 27.40

+6.41%

TLL

Trident Lifeline Ltd.

₹ 262.50

-0.61%

DPL

Dipna Pharmachem Ltd.

₹ 5.76

-8.86%

ACHYUT

Achyut Healthcare Ltd.

₹ 8.20

+0.12%

SIGACHI

Sigachi Industries Ltd.

₹ 22.67

+1.98%

WINDLAS

Windlas Biotech Ltd.

₹ 830.00

+0.50%

VINEETLAB

Vineet Laboratories Ltd.

₹ 32.80

+0.43%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 38.55

-4.98%

CHCL

Cian Healthcare Ltd.

₹ 8.67

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 568.90

+0.36%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.41

+0.00%

ZIMLAB

Zim Laboratories Ltd.

₹ 113.62

-1.99%

BPLPHARMA

Bharat Parenterals Ltd.

₹ 1402.00

-0.61%

MEDICO

Medico Remedies Ltd.

₹ 39.10

+0.03%

SGRL

Shree Ganesh Remedies Ltd.

₹ 687.00

+1.43%

FAQ's on APPL

What is the Market Capitalization of Aptus Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 9 July 2026, the market cap for Aptus Pharma Ltd. is approximately ₹ 376.9 Cr.

What are the PE and PB ratios for Aptus Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Aptus Pharma Ltd. is 81.6, and the Price-to-Book (PB) ratio is 16.1.

What is the 52-Week High and Low for Aptus Pharma Ltd.?

Over the past 52 weeks, the highest price reached by Aptus Pharma Ltd. shares was ₹ 238.8, and the lowest price was ₹ 32.32.

Who are the major shareholders of Aptus Pharma Ltd.?

Significant shareholdings in Aptus Pharma Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Aptus Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Aptus Pharma Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy